CBD for Pets: Navigating Quality Assurance, Safety Standards, and Marketing Strategies
As the human cannabinoid (CBD) market grows, the same or similar products are inevitably transferred into the veterinary sector. Advances...
Effects of Terpenes on the Osteoarthritis Cytokine Profile by Modulation of IL-6: Double Face versus Dark Knight?
Sep 2, 2024
Terpenes are emerging as a new complementary therapy for several chronic diseases, but their effects on inflammatory cytokines are not...
Therapeutic efficacy and pharmacokinetics of liposomal-cannabidiol injection: a pilot clinical study in dogs with naturally-occurring osteoarthritis
Sep 2, 2024
Osteoarthritis is a common disease in dogs resulting in chronic pain and decreased wellbeing. Common analgesics such as non-steroidal anti-inflammatories...
Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trial
Sep 2, 2024
In this trial, plant-derived high-dose oral CBD given for 8 weeks as an add-on to continued paracetamol was not superior...
Impact of Cannabidiol and Exercise on Clinical Outcomes and Gut Microbiota for Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors: A Case Report
Sep 2, 2024
Chemotherapy-induced peripheral neuropathy (CIPN) remains a clinical challenge for up to 80% of breast cancer survivors. In an open-label study,...
Therapeutic Prospects of Cannabinoids in the Immunomodulation of Prevalent Autoimmune Diseases
Sep 2, 2024
Data from experimental animal models of AD showed that natural and synthetic cannabinoids downregulate inflammatory responses mediated by immune cells...
Immune Responses Regulated by Cannabidiol
Sep 2, 2024
Cannabidiol (CBD) as Epidiolex® (GW Pharmaceuticals) was recently approved by the U.S. Food and Drug Administration (FDA) to treat rare...
Canine immune cells express high levels of CB1 and CB2 cannabinoid receptors and cannabinoid-mediated alteration of canine cytokine production is vehicle-dependent
Sep 2, 2024
With the increased popularity and societal acceptance of marijuana and cannabidiol (CBD) use in humans, there is an interest in...
Potential to use cannabinoids as adjunct therapy for dexamethasone: An in vitro study with canine peripheral blood mononuclear cells
Sep 2, 2024
Dexamethasone (dex) is a potent glucocorticoid used to treat a variety of diseases. It is widely used in veterinary medicine...
Use of cannabis in the treatment of animals: a systematic review of randomized clinical trials
Sep 2, 2024
Cannabis is used in the treatment of several human conditions; however, its use is still less explored in veterinary medicine....
Search Our Website
Recent In The News
- CBD Oracle Interviews VCS Board and Sponsors
- New York Times: Mammals with the Munchies
- Check out this article highlighting VCS in the newest issue of “Cannabis and Tech Today.
- BREAKING NEWS! Check out this recently released statement from the U.S. Food and Drug Administration about next steps to explore potential regulatory pathways for CBD products!
- Cannabis in Veterinary Medicine | Continual Education | VIN
- Check out this conversation with VCS Founders Dr. Gary Richter, Dr. Trina Hazzah, and Charles Lozow on the importance of advocating for the safe use of cannabis in pets
- A Dose Finding Study of Cannabidiol in Dogs with Intractable Epilepsy
- Earth Buddy, Pet Calming Study – Press Release
- CALIFORNIA CANNABIS UPDATES – April 2022
- Cannabis in Veterinary Practice Multi-Expert Webinar